Header Logo

Connection

RACHELLE DOODY to Acetamides

Back to Details
This is a "connection" page, showing publications RACHELLE DOODY has written about Acetamides.
RACHELLE DOODY
Connection Strength
0.136
Acetamides
  1. Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD). J Alzheimers Dis. 2017; 58(4):1217-1228.
    View in: PubMed
    Score: 0.136
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.